| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 5,514 | 8,958.5* | 4,632 | 3,219 |
| Amortization and impairment loss of license and patent | NaN | 1,500* | 1,500 | 1,000 |
| Cost of revenue | 1,401 | 1,375.5* | 781 | 2,156 |
| Impairment of inventory | NaN | 0* | 0 | 0 |
| Gross profit (loss) | 4,113 | 7,583 | 3,851 | 1,063 |
| General and administrative | 181,050 | 228,262 | 250,971 | 197,892 |
| Professional fees | 19,781 | 25,938 | 17,069 | 81,390 |
| Depreciation | 1,500 | NaN | NaN | NaN |
| Total operating expenses | 202,331 | 255,700 | 269,540 | 280,282 |
| Gain on settlement of debt | NaN | 32,100* | 101,700 | NaN |
| Loss from operations | -198,218 | -248,117 | -265,689 | -279,219 |
| Other income | 5 | 0* | 0 | 0 |
| Interest expense | 87,757 | 37,431 | 14,153 | 9,649 |
| Change in fair value of derivative liabilities | 174,884 | -569,898 | -201,360 | 130,954 |
| Total other income | 87,132 | -575,229 | -113,813 | 121,305 |
| Loss before income taxes | -111,086 | -823,346 | -379,502 | -157,914 |
| Net loss | -111,086 | -823,346 | -379,502 | -157,914 |
| Diluted EPS | -0.01 | -0.072 | -0.04 | 0.02 |
| Diluted Average Shares | 12,008,725 | 11,468,862 | 10,239,290 | 9,533,375 |
BIOADAPTIVES, INC. (BDPT)
BIOADAPTIVES, INC. (BDPT)